![]() |
市场调查报告书
商品编码
1567783
欧洲水生兽医市场预测至 2030 年 - 区域分析 - 按类型、诊断、治疗、物种、疾病来源和给药途径Europe Aquatic Veterinary Market Forecast to 2030 - Regional Analysis - by Type, Diagnostic, Treatment, Species, Diseases Source, and Route of Administration |
2022年欧洲水生兽医市场价值4.1503亿美元,预计到2030年将达到5.3977亿美元;预计2022年至2030年复合年增长率为3.3%。
水生动物物种消费需求激增推动欧洲水产兽医市场
鱼、螃蟹、淡菜和龙虾都是人类食用的水生动物。对海鲜的需求不断增加,导致全球鱼类供应增加,促进了水产养殖业的发展。鱼类具有丰富的营养素,包括维生素、蛋白质、脂肪酸、重要的微量营养素和矿物质。它们被认为是 omega-3 脂肪酸的极佳来源。人们已经研究了 Omrega-3 脂肪酸与降低心臟病发作风险、预防儿童气喘和忧郁症以及改善大脑健康的关係。根据经济合作暨发展组织 (OECD) 的数据,到 2029 年,全球鱼类产量预计将达到 200 吨。将拥有大量蛋白质、营养物质和矿物质。它们的饱和脂肪含量很少,是 omega-3 不饱和脂肪——二十二碳六烯酸 (DHA) 和二十碳五烯酸 (EPA) 的重要来源。人们也研究了螃蟹的营养成分对关节疼痛和高血管压力的影响。食用螃蟹的其他好处包括改善骨骼和心臟健康以及情绪健康。全球水生动物消费量的增加随后导致了产量的激增。例如,根据联邦渔业局的数据,俄罗斯螃蟹产量从2017年的8.63万吨增加到2020年的9.33万吨。和饲料。这些营养素和饲料可以透过施用疫苗和补充剂来提供。因此,对海鲜产品不断增长的需求带动了欧洲水产兽医市场。
欧洲水产兽医市场概况
由于德国水产养殖和渔业的持续发展,德国的欧洲水生兽医市场可能会成长。该国拥有各种水产养殖企业,主要集中于养殖和生产虹鳟鱼、鲤鱼、贻贝等。据同一消息来源称,2021 年贻贝产量增加 5.8%,达到近 14,300 吨。鱼类产量的增加以及生产过程中对鱼类健康意识的增强是推动欧洲水产兽医市场成长的因素。 2022 年1 月,德国海水养殖协会(Gesellschaft Fur Marine Aquakultur mbH, GMA) 的一个研究团队与位于吕贝克的弗劳恩霍夫个性化和细胞医学工程IMTE 研究所合作,进一步巩固该机构在该领域的专业知识。这为该研究所提供了第二个基地,同时加强德国北部的海洋经济并推广创新技术以改善水产养殖的生态和经济平衡表。水产养殖和渔业领域的这种发展支撑了德国的欧洲水生兽医市场。
欧洲水生兽医市场收入及 2030 年预测(百万美元)
欧洲水产兽医市场细分
欧洲水生兽医市场按类型、种类、疾病来源、给药途径及国家分类。
根据类型,欧洲水生兽医市场分为诊断和治疗。到 2022 年,治疗细分市场将占据更大的市场份额。治疗部分进一步细分为疫苗、药物和补充剂。
依物种划分,欧洲水生兽医市场分为鱼类、甲壳类、软体动物等。 2022 年,鱼类细分市场占据最大的市场份额。
根据疾病来源,欧洲水生兽医市场分为细菌、病毒、寄生虫等。 2022 年,细菌细分市场占据最大的市场。
从给药途径来看,欧洲水产兽医市场分为水用药、药饲料和其他给药途径。 2022 年,水药物领域占据最大的市场份额。
依国家划分,欧洲水生兽医市场分为英国、德国、法国、西班牙、义大利和欧洲其他国家。 2022年,德国在欧洲水生兽医市场份额中占据主导地位。
Aquatic Diagnostics Ltd、Ceva Polchem Pvt Ltd、Elanco Animal Health Inc、Esox Biologics Ltd、HIPRA SA、Merck KGaA、Phibro Animal Health Corp、Thermo Fisher Scientific Inc、Virbac SA 和 Zoetis Inc 是在欧洲运营的一些领先公司水产兽医市场。
The Europe aquatic veterinary market was valued at US$ 415.03 million in 2022 and is expected to reach US$ 539.77 million by 2030; it is estimated to register a CAGR of 3.3% from 2022 to 2030.
Surging Demand for Aquatic Animal Species for Consumption Drives Europe Aquatic Veterinary Market
Fishes, crabs, mussels, and lobsters are among the aquatic animals that are used for human consumption. The increasing demand for seafood results in a greater fish supply worldwide, which, in turn, boosts the aquaculture industry. Fishes have a rich nutritional profile, including vitamins, proteins, fatty acids, vital micronutrients, and minerals. They are known as an excellent source of omega-3 fatty acids. Omrega-3 fatty acids have been studied for their association with the reduction of risk of heart attacks, prevention of childhood asthma and depression, and improvement of brain health. As per the Organization for Economic Cooperation and Development (OECD), global fish production volume is expected to reach 200 metric ton by 2029. Further, nearly 90% of the fish produced (i.e., ~180 metric ton) would be consumed as food by humans by 2029. Significant amounts of proteins, nutrients, and minerals are found in crabs. They have little saturated fat content and are an important source of omega-3 unsaturated fats-docosahexaenoic acid (DHA) and Eicosapentaenoic Acid (EPA). The nutrient profile of crabs has also been studied for its effects against joint pain and high vascular stress. Other benefits of crab consumption include bone and heart health improvements, and emotional well-being. The globally increasing consumption of aquatic animals is subsequently leading to an upsurge in production. For instance, as per the Federal Agency for Fishery, the production volume of crab in Russia increased from 86.3 thousand metric tons in 2017 to 93.3 thousand metric tons in 2020. With the increasing consumption of seafood, there is a growing need for high-quality produce, which requires proper nutrients and feeds. These nutrients and feeds can be provided by the administration of vaccines and supplements. Therefore, the growing demand for seafood products drives the Europe aquatic veterinary market.
Europe Aquatic Veterinary Market Overview
The Europe aquatic veterinary market in Germany is likely to grow due to ongoing developments in the country's aquaculture and fishery industry. The country has the presence of various aquaculture businesses, majorly focusing on culturing and producing rainbow trout, common carp, mussels, etc. According to the Federal Statistical Office, ~18,300 metric ton of fishes were produced in Germany in 2021 by 2,200 aquaculture businesses. As per the same source, the production of mussels rose by 5.8% to reach nearly 14,300 metric ton in 2021. The production of roe and caviar increased from 9 metric ton to ~85 metric ton. The increase in the production of fish and growing awareness about the health of the fish during production are factors fueling the growth of the Europe aquatic veterinary market. In January 2022, a research team at the German Society for Marine Aquaculture (Gesellschaft fur Marine Aquakultur mbH, GMA) collaborated with the Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering IMTE in Lubeck to further consolidate the institution's expertise in this area. This provides the research institute with a second site, alongside strengthening the maritime economy in northern Germany and promoting innovative technologies to improve the ecological and economic balance sheet of aquaculture. Such development in the aquaculture and fisheries sector bolsters the Europe aquatic veterinary market in Germany.
Europe Aquatic Veterinary Market Revenue and Forecast to 2030 (US$ Million)
Europe Aquatic Veterinary Market Segmentation
The Europe aquatic veterinary market is categorized into type, species, diseases source, route of administration, and country.
Based on type, the Europe aquatic veterinary market is bifurcated diagnostic and treatment. The treatment segment held a larger market share in 2022. The diagnostic segment is further sub segmented into serological, molecular, DNA sequencing, and other diagnostics. The treatment segment is further sub segmented into vaccines, medications, and supplements.
By species, the Europe aquatic veterinary market is segmented into fish, crustaceans, mollusca, and others. The fish segment held the largest market share in 2022.
Based on diseases source, the Europe aquatic veterinary market is segmented into bacterial, viral, parasites, and others. The bacterial segment held the largest market share in 2022.
In terms of route of administration, the Europe aquatic veterinary market is segmented into water medication, medicated feed, and other route of administrations. The water medication segment held the largest market share in 2022.
By country, the Europe aquatic veterinary market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe aquatic veterinary market share in 2022.
Aquatic Diagnostics Ltd, Ceva Polchem Pvt Ltd, Elanco Animal Health Inc, Esox Biologics Ltd, HIPRA SA, Merck KGaA, Phibro Animal Health Corp, Thermo Fisher Scientific Inc, Virbac SA, and Zoetis Inc are some of the leading companies operating in the Europe aquatic veterinary market.